Cellectar Biosciences
Pre-clinicalAt Cellectar, we are developing precision medicine and personalized cancer treatments using our novel and validated Phospholipid Drug Conjugate Phospholipid Drug Conjugate (PDC)™ platform which possesses the capacity to deliver a broad array of targeted oncology therapeutics.
Founded
1999
Focus
Small Molecules
About
At Cellectar, we are developing precision medicine and personalized cancer treatments using our novel and validated Phospholipid Drug Conjugate Phospholipid Drug Conjugate (PDC)™ platform which possesses the capacity to deliver a broad array of targeted oncology therapeutics.
Company Info
TypePrivate
Founded1999
LocationFlorham Park, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile